{ "kind": "all", "value": "all", "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations", "filters": { "documentKinds": [], "sourceTypes": [], "orientations": [] }, "total": 319975, "page": 2729, "pageSize": 60, "pageCount": 5333, "rows": [ { "docId": "019de071-37fe-7321-9fb6-d46993a6dfbe", "docSlug": "11c74dd03d1e36923d1ba60a48e75a21", "documentTitle": "Amazon | Results Presentation Deck | 19 slides", "authorId": "amazon", "authorName": "Amazon", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.3087934, "pageNumber": 19, "slideType": "appendix_data", "function": "analyze_data", "notes": "TTM stands for Trailing Twelve Months. The table provides a breakdown of cash flow adjustments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-37fe-7321-9fb6-d46993a6dfbe/19", "deckHref": "/decks/019de071-37fe-7321-9fb6-d46993a6dfbe", "deckAnchorHref": "/decks/019de071-37fe-7321-9fb6-d46993a6dfbe#slide-19", "loopMatches": [], "arcBeatMatches": [ { "to": 19, "from": 16, "beatId": "a3bd65c9-82c6-447f-81d4-9f4ac600e53d", "arcName": "The Sparkline", "arcSlug": "sparkline", "beatName": "Appendix", "beatSlug": null, "evidence": "Appendix slides with additional data and reconciliations", "position": 3, "confidence": 0.8, "parentBeatName": null, "parentBeatSlug": null } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 1, "slideType": "cover", "function": "front_matter", "notes": "The infinity symbol is used as a framing device for the imagery.", "imagePath": "https://imgproxy.kitesheet.com/esJsB-CkAlfIAcawIttmBbdTZfNt5FhfYBd4kKpnOWY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84ZTY4Yzc3NjNjODRkMWI0ODVlMTJmODI4YzNiMGQ3ZS9wMDAxLmpwZw", "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/1", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-1", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 1, "beatId": "3deee1d5-0171-495d-8d4b-86edeeed3ec9", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Introduction and agenda setting", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": "https://imgproxy.kitesheet.com/eaq0vMdWDgR7NiBluNilUpz5KfH8gjyuTmzES-PTVZw/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84ZTY4Yzc3NjNjODRkMWI0ODVlMTJmODI4YzNiMGQ3ZS9wMDAxLnBuZw", "thumbSrc": "https://imgproxy.kitesheet.com/kgYqxi8QCu1XlgRsBFmJmaOvVsnUFZVCsqmuugbzXdw/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84ZTY4Yzc3NjNjODRkMWI0ODVlMTJmODI4YzNiMGQ3ZS9wMDAxLmpwZw", "thumbSrcAlt": "https://imgproxy.kitesheet.com/x1V-0u5e7OUCXAj4fyB07jGp3c2vLbp0ulNH9GzY-mc/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy84ZTY4Yzc3NjNjODRkMWI0ODVlMTJmODI4YzNiMGQ3ZS9wMDAxLnBuZw" }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 2, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/2", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-2", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 1, "beatId": "3deee1d5-0171-495d-8d4b-86edeeed3ec9", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Introduction and agenda setting", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 3, "slideType": "disclaimer", "function": "other", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/3", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-3", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 1, "beatId": "3deee1d5-0171-495d-8d4b-86edeeed3ec9", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Introduction and agenda setting", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 4, "slideType": "agenda", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/4", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-4", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 1, "beatId": "3deee1d5-0171-495d-8d4b-86edeeed3ec9", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Introduction and agenda setting", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 5, "slideType": "appendix", "function": "state_next_steps", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/5", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-5", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 1, "beatId": "3deee1d5-0171-495d-8d4b-86edeeed3ec9", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Introduction and agenda setting", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 6, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/6", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-6", "loopMatches": [], "arcBeatMatches": [ { "to": 6, "from": 1, "beatId": "3deee1d5-0171-495d-8d4b-86edeeed3ec9", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Situation & Context", "beatSlug": "consultants-gambit-situation-context", "evidence": "Introduction and agenda setting", "position": 0, "confidence": 0.8, "parentBeatName": "Setup", "parentBeatSlug": "setup" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 7, "slideType": "cover", "function": "front_matter", "notes": "The slide uses an infinity loop to symbolize the continuous cycle between patient and science.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/7", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-7", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 8, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a 2x3 grid layout to present five key strategic pillars.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/8", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-8", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 9, "slideType": "other", "function": "present_solution", "notes": "The slide uses a hub-and-spoke visual metaphor to show the drug's broad applicability across multiple disease states.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/9", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-9", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 10, "slideType": "other", "function": "present_solution", "notes": "The slide uses a process-like flow to connect disease states to specific clinical data and future opportunities.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/10", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-10", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 11, "slideType": "comparison_table", "function": "present_solution", "notes": "The slide uses a comparison matrix structure to justify the expansion of a clinical franchise into a new indication.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/11", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-11", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 12, "slideType": "other", "function": "present_framework", "notes": "The diagram is a variation of a flywheel or infinity loop process.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/12", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-12", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 13, "slideType": "other", "function": "present_framework", "notes": "The slide uses a biological neuron metaphor to illustrate a business platform strategy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/13", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-13", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 14, "slideType": "key_messages", "function": "summarize", "notes": "The slide uses a Venn-like diagram to connect core company values to specific market and pipeline achievements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/14", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-14", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 15, "slideType": "key_takeaways", "function": "summarize", "notes": "The slide uses a Venn-like diagram to connect three core pillars to six specific business achievements.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/15", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-15", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 16, "slideType": "cover", "function": "front_matter", "notes": "The slide features a stylized circular cutout showing a smiling woman, set against a background of molecular structures.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/16", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-16", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 17, "slideType": "other", "function": "present_framework", "notes": "The slide uses a numbered list to explain a biological process (pinocytosis, binding, rescue, release) mapped to a visual diagram.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/17", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-17", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 18, "slideType": "other", "function": "present_framework", "notes": "The slide uses a numbered process/comparison flow to contrast binding modes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/18", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-18", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 19, "slideType": "other", "function": "analyze_data", "notes": "The chart shows that Efgartigimod maintains FcRn volume similar to 'No treatment', whereas the 'Control anti-FcRn mAb' causes a significant reduction in volume over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/19", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-19", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 20, "slideType": "other", "function": "present_framework", "notes": "The slide uses a causal flow diagram to explain the mechanism of action.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/20", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-20", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 21, "slideType": "before_after", "function": "analyze_data", "notes": "Data from Phase 3 ADAPT trial; includes comparison to Phase 2 pemphigus trial findings.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/21", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-21", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 22, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/22", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-22", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 23, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/23", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-23", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 24, "slideType": "problem_statement", "function": "frame_problem", "notes": "The slide uses a structured layout to define the disease state and market opportunity.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/24", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-24", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "997aa06c-e939-48b0-b970-55ff94a49394", "evidence": "Discussion of current treatment limitations", "position": 0, "objective": "Highlight the need for new treatments in myositis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 28, "from": 24, "beatId": "00c05735-0296-42af-85b4-d63d3913b672", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "Discussion of myositis and its pathophysiology", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 25, "slideType": "key_messages", "function": "present_framework", "notes": "The diagram uses a bubble-cluster visualization to show the relationship between different autoantibodies and clinical conditions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/25", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-25", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "997aa06c-e939-48b0-b970-55ff94a49394", "evidence": "Discussion of current treatment limitations", "position": 0, "objective": "Highlight the need for new treatments in myositis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 28, "from": 24, "beatId": "00c05735-0296-42af-85b4-d63d3913b672", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "Discussion of myositis and its pathophysiology", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 26, "slideType": "other", "function": "present_framework", "notes": "The slide uses a circular process flow to explain the pathology of Immune-Mediated Necrotizing Myopathy (IMNM).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/26", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-26", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "997aa06c-e939-48b0-b970-55ff94a49394", "evidence": "Discussion of current treatment limitations", "position": 0, "objective": "Highlight the need for new treatments in myositis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 28, "from": 24, "beatId": "00c05735-0296-42af-85b4-d63d3913b672", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "Discussion of myositis and its pathophysiology", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 27, "slideType": "other", "function": "present_framework", "notes": "The slide uses a process-flow framework to show how autoantibodies trigger specific biological pathways (myolysis, capillary disruption, interferon production) leading to muscle atrophy.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/27", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-27", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "997aa06c-e939-48b0-b970-55ff94a49394", "evidence": "Discussion of current treatment limitations", "position": 0, "objective": "Highlight the need for new treatments in myositis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 28, "from": 24, "beatId": "00c05735-0296-42af-85b4-d63d3913b672", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "Discussion of myositis and its pathophysiology", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 28, "slideType": "other", "function": "present_framework", "notes": "The diagram illustrates a hub-and-spoke model where the autoantibody is the central mediator.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/28", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-28", "loopMatches": [ { "to": 28, "from": 24, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "997aa06c-e939-48b0-b970-55ff94a49394", "evidence": "Discussion of current treatment limitations", "position": 0, "objective": "Highlight the need for new treatments in myositis", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "arcBeatMatches": [ { "to": 28, "from": 24, "beatId": "00c05735-0296-42af-85b4-d63d3913b672", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "Discussion of myositis and its pathophysiology", "position": 1, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 29, "slideType": "key_messages", "function": "present_framework", "notes": "The slide illustrates the diversity of autoantibodies in myositis patients, supporting the thesis that a broad-acting therapy like Efgartigimod is effective.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/29", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-29", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 30, "slideType": "key_messages", "function": "establish_context", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/30", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-30", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 31, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide shows 8 individual patient longitudinal plots. Each plot has dual y-axes (CK and Anti-SRP54) and a shared x-axis (Days).", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/31", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-31", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 32, "slideType": "key_takeaways", "function": "summarize", "notes": "The chart is a Kaplan-Meier survival curve showing 'DOI-free Survival Probability' over time in weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/32", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-32", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 33, "slideType": "before_after", "function": "analyze_data", "notes": "ProDERM study data comparing IVIg and placebo efficacy over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/33", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-33", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 34, "slideType": "other", "function": "illustrate_case", "notes": "Includes two dot plots showing grip/muscle strength and two microscopy images showing necrosis and complement deposition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/34", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-34", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 35, "slideType": "market_sizing", "function": "size_opportunity", "notes": "The chart uses a diagonal line to represent growth or accumulation of patient segments.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/35", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-35", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 36, "slideType": "appendix_methodology", "function": "present_framework", "notes": "The slide outlines a clinical trial protocol involving 180 patients, stratified by condition and severity, with a 26-week duration and specific primary/secondary endpoints.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/36", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-36", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 37, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/37", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-37", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 38, "slideType": "cover", "function": "front_matter", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/38", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-38", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 39, "slideType": "executive_summary", "function": "frame_problem", "notes": "The slide uses a structured 4-column layout to summarize the disease profile.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/39", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-39", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 40, "slideType": "other", "function": "illustrate_case", "notes": "The slide depicts a step-by-step biological pathway (1-6) showing how autoantibodies lead to blister formation. It also highlights the therapeutic target Efgartigimod.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/40", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-40", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 41, "slideType": "before_after", "function": "analyze_data", "notes": "The slide uses a before-after structure to contrast WT mice (susceptible) with FcRn-/- mice (resistant) and shows the impact of HDIG treatment.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/41", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-41", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 42, "slideType": "comparison_table", "function": "present_framework", "notes": "The funnel structure implies a progression toward higher selectivity and better outcomes.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/42", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-42", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 43, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide presents three distinct clinical datasets (IVIg, Protein A Immunoadsorption, and PLEX) to support the thesis that IgG-targeted therapies lead to fast remissions.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/43", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-43", "loopMatches": [ { "to": 43, "from": 29, "name": "Aha Moment", "slug": "03-aha-moment", "bestFor": "Data-heavy sections, research findings, analytical arguments", "matchId": "2d58beec-e58f-42d6-98ee-47f2b7cb1adf", "evidence": "Data presentation and analysis", "position": 1, "objective": "Reveal the potential of Efgartigimod", "structure": "The Problem/Question -> What the Data Shows -> The Insight", "confidence": 0.8, "description": "Establish a tension, present data, then deliver the insight that changes everything" } ], "arcBeatMatches": [ { "to": 43, "from": 29, "beatId": "002ee641-6d99-4db6-a151-22313bbe3e4f", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Evidence & Proof", "beatSlug": "consultants-gambit-evidence-proof", "evidence": "Data supporting Efgartigimod's effectiveness", "position": 2, "confidence": 0.8, "parentBeatName": "Evidence", "parentBeatSlug": "evidence" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 44, "slideType": "before_after", "function": "present_solution", "notes": "Uses a horizontal progression arrow to show the transition from initial indication to adjacent indications.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/44", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-44", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 45, "slideType": "other", "function": "present_framework", "notes": "Clinical trial design diagram showing a 1:1 randomization between Efgartigimod and Placebo over 36 weeks.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/45", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-45", "loopMatches": [], "arcBeatMatches": [], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 46, "slideType": "key_takeaways", "function": "summarize", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/46", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-46", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 47, "slideType": "cover", "function": "front_matter", "notes": "Branded Argenx presentation slide.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/47", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-47", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 48, "slideType": "nominee_bio", "function": "introduce_nominees", "notes": null, "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/48", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-48", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 49, "slideType": "cover", "function": "front_matter", "notes": "Includes names of presenters and company logo.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/49", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-49", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 50, "slideType": "propose_solution", "function": "present_solution", "notes": "The diagram shows the classical, lectin, and alternative pathways converging at C3 convertase, with C2 highlighted as a target.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/50", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-50", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 51, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to illustrate the complement system and justifies targeting C2 over other components.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/51", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-51", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 52, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to explain the mechanism of action for a potential therapeutic intervention.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/52", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-52", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 53, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a biological pathway diagram to justify a therapeutic target.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/53", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-53", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 54, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a process flow diagram to justify targeting C2. It contrasts this with other potential targets (labeled 1 and 2) and highlights the benefits of C2 inhibition.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/54", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-54", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 55, "slideType": "propose_solution", "function": "present_solution", "notes": "The slide uses a circular process diagram to explain the biological mechanism of the drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/55", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-55", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 56, "slideType": "other", "function": "present_framework", "notes": "The slide uses a timeline-like structure to show dose escalation cohorts for IV and SC administration.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/56", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-56", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 57, "slideType": "kpi_overview", "function": "analyze_data", "notes": "The slide presents clinical trial safety data for ARGX-117, highlighting that most adverse events are low grade and unrelated to the drug.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/57", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-57", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 58, "slideType": "key_takeaways", "function": "analyze_data", "notes": "SAD = Single Ascending Dose. PD = Pharmacodynamic.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/58", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-58", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }, { "docId": "019de071-38a0-778d-8d39-45a206af86ac", "docSlug": "8e68c7763c84d1b485e12f828c3b0d7e", "documentTitle": "argenx SE | Investor Day Presentation Deck | 69 slides", "authorId": "argenx-se", "authorName": "argenx", "documentKindSlug": "conference-presentation", "documentKindLabel": "Conference presentation", "sourceTypeSlug": "investor_relations", "sourceTypeLabel": "Investor relations", "presentationDate": "2021-07-01 00:00:00", "orientation": "landscape", "aspectRatio": 1.7777778, "pageNumber": 59, "slideType": "key_takeaways", "function": "analyze_data", "notes": "The slide shows two line charts comparing different dosing regimens over time.", "imagePath": null, "matchCount": 1, "evidence": null, "slideHref": "/slides/019de071-38a0-778d-8d39-45a206af86ac/59", "deckHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac", "deckAnchorHref": "/decks/019de071-38a0-778d-8d39-45a206af86ac#slide-59", "loopMatches": [], "arcBeatMatches": [ { "to": 69, "from": 46, "beatId": "20be018b-29e0-462d-a14d-4277066d2678", "arcName": "The Consultant's Gambit", "arcSlug": "consultants-gambit", "beatName": "Impact & Next Steps", "beatSlug": "consultants-gambit-impact-next-steps", "evidence": "Conclusion and Q&A session", "position": 3, "confidence": 0.8, "parentBeatName": "Resolution", "parentBeatSlug": "resolution" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true } ] }